Eli Lilly Says Genentech Owes $10M In 'Unwinnable' Suit Fees
Genentech knew it had no case when it accused Eli Lilly in California federal court of infringing its patent through the sale of a psoriasis drug, the latter said Wednesday in...To view the full article, register now.
Already a subscriber? Click here to view full article